Biotechnology and biopharmaceuticals : transforming proteins and genes into drugs
著者
書誌事項
Biotechnology and biopharmaceuticals : transforming proteins and genes into drugs
Wiley-Liss, c2003
- : pbk
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and indexes
内容説明・目次
内容説明
Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs defines biotechnology from the perspective of pharmaceuticals. The first section focuses on the process of transforming a biologic macromolecule into a therapeutic agent, while the second section provides a brief overview of each class of macromolecule with respect to physiological role and clinical application. Additional detail is also provided in the second section for each FDA approved, recombinantly derived biopharmaceutical for each category of macromolecule. The final section looks to the future and the new advances that will enhance our ability to develop new macromolecules into effective biopharmaceuticals. This last section discusses various drug delivery strategies while also describing gene and cell therapy strategies.
目次
Foreword. Preface. Organization of the Book. Contributors. PART I: TRANSFORMING PROTEINS AND GENES INTO THERAPEUTICS. 1. Introduction to Biopharmaceuticals. 1.1. Biotechnology versus Pharmaceutical Biotechnology. 1.2. Historical Perspective of Pharmaceutical Biotechnology. 1.3. Not All Protein Drugs and Vaccines of the Same Name Are Identical. 2. Comparative Drug Development of Proteins and Genes versus Small Molecules. 2.1. Transforming New Molecular Entities into Drugs. 2.2. Differences between Development of Biotechnology Products of Macromolecules and Chemical Products. 2.3. Current Trends in Drug Development. 3. Biotechnology Industry Perspective on Drug Development. 3.1. Introduction. 3.2. Role of the Orphan Drug Act. 3.3. Clinical Leverage Strategy in Accelerating Drug Development. 3.4. Therapeutic Target Considerations. 4. Biopharmaceutical Technologies and Processes in Drug Development. 4.1. Application of Biotechnologies in Drug Discovery and Development. 4.2. Large-Scale Production of Recombinant Proteins. 4.3. Biologic Drug Development and Approval. 5. Pharmacology, Toxicology, Therapeutic Dosage Formulations, and Clinical Response. 5.1. Clinical Pharmacology. 5.2. Dose and Therapeutic Response. 5.3. Dosage Form and Routes of Administration. PART II: THERAPEUTICS BASED ON BIOTECHNOLOGY. 6. Hematopoietic Growth Factors and Coagulation Factors. 6.1. Overview. 6.2. Monographs. 7. Interferons and Cytokines for Anti-infective and Cancer Therapy. 7.1. Interferons in Cancer Therapy (Mamta Chawla-Sarkar, Paul Masci, and Ernest Borden). 7.2. Interferons in Viral Hepatitis (Gary L. Davis). 7.3. Interferon-b in the Treatment of Multiple Sclerosis. 7.4. Monographs. 8. Hormones. 8.1. Protein Hormones as Therapeutics:Yesterday, Today, and Tomorrow (Sandra Blethen 8.2. Monographs. 9. Enzymes. 9.1. Overview of Enzyme Therapies. 9.2. Monographs. 10. Antibodies and Derivatives. 10.1. Overview. 10.2. Monographs. 11. Vaccines (Shiu-Lok Hu and Rodney J.Y. Ho). 11.1. Why Vaccines? 11.2. How Do Vaccines Work? 11.3. Traditional Vaccine Approaches. 11.4. Subcellular and Recombinant Subunit Vaccines. 11.5. Future Directions. 11.6. Summary. 12. Other Products: Monographs. PART III: FUTURE DIRECTIONS. 13. Advanced Drug Delivery. 13.1. Rationale and Basic Principles. 13.2. Physiologic and Mechanistic Approaches. 13.3. Approaches Using Devices. 13.4. Molecular Approaches. 13.5. Summary. 14. Individualization of Drug Regimens: Integration of Pharmacokinetic and Pharmacogenetic Principles in Drug Therapy. 14.1. Overview of Factors Governing Interindividual Variations. 14.2. Historical Perspective on Pharmacogenetics. 14.3. Pharmacogenetics: Drug Metabolism and Transport. 14.4. Pharmacogenetics: Therapeutic Response. 14.5. Individualized Gene-Based Medicine: A Mixed Blessing. 14.6. Current and Potential Application of Pharmacogenetics. 14.7. Summary. 15. Gene and Cell Therapy. 15.1. Overview of Gene and Cell Therapeutics. 15.2. Delivery and Expression of Genes Encoded for Functional Proteins (Sean M. Sullivan). 16. Integration of Discovery and Development: The Role of Genomics and Proteomics. 16.1. Overview. 16.2. Integration of Discovery and Development of Therapeutic Candidates. 16.3. Genomics: The First Link between Sequences and Drug Targets. 16.4. Proteomics: From Sequences to Functions. 16.5. Integrating Proteomic and Genomic Tools to Accelerate Drug Development. 16.6. Summary. Appendix I: Dosage Form, Pharmacokinetics, and Disposition Data. Appendix II: Molecular Characteristic and Therapeutic Use. Appendix III: Nomenclature of Biotechnology Products. Appendix IV: Synonyms of Trade, Common, and Scientific Names. Appendix V: Other Information Tables. Index. Monographs Index.
「Nielsen BookData」 より